Gregg L. Katz

Gregg L. Katz

Partner
Gregg L. Katz

Gregg Katz, a partner in Goodwin’s Technology Companies Group, works on a wide variety of public and private securities offerings, mergers and acquisitions and other complex transactions. His practice centers on technology companies, including clients in the software, hardware, biotechnology, pharmaceuticals and other technology-driven industries.

Mr. Katz’ representation of start-up and later-stage companies spans the entire corporate lifecycle, including pre-incorporation planning, venture capital financings, public offerings, SEC reporting and disclosure, mergers and acquisitions, and general corporate representation and counseling.

Experience

Mr. Katz’ transactional experience includes representing:

Public Offerings

  • Goldman Sachs, Credit Suisse and Bank of America in the $113 million initial public offering of Alarm.com on NASDAQ
  • Goldman Sachs and Deutsche Bank in the $235 million and $344 million follow-on public offerings of CyberArk Software
  • Alnylam Pharmaceuticals, a biopharmaceutical company developing novel therapeutics based on RNA interference, in its $517 million follow-on public offering
  • J.P. Morgan and Deutsche Bank in the $99 million initial public offering of CyberArk Software on NASDAQ
  • Goldman Sachs and Credit Suisse in the $133 million initial public offering of 2U on NASDAQ
  • bluebird bio, a clinical-stage company developing gene therapies for severe genetic and orphan diseases, in its $116 million initial public offering on NASDAQ and $117 million, $259 million and $500 million follow-on public offerings
  • Omthera Pharmaceuticals, a pharmaceutical company focused on therapies for abnormalities in blood lipids and the treatment of cardiovascular disease, in its $64 million initial public offering on NASDAQ
  • Eloqua, a provider of on-demand revenue performance management software solutions, in its $106 million initial public offering on NASDAQ

Private Financings

  • Alnylam Pharmaceuticals, a biopharmaceutical company developing novel therapeutics based on RNA interference, in a $700 million equity financing closed in connection with Alnylam’s collaboration with Genzyme
  • Salsify, a software company focused on the management and exchange of product information across the retail supply chain, in its $8 million Series A financing and $17 million Series B financing
  • Infinio Systems, a leader in storage acceleration for virtualized data centers, in its $12 million Series B financing
  • Circle Internet Financial, a digital currency company, in its $9 million Series A financing, $17 million Series B financing and $50 million Series C financing
  • Bedford Funding in its $36 million Series C investment in Voalte and $50 million Series D investment in MDLIVE

Mergers & Acquisitions

  • Epidemico, an informatics company providing early insights, continuous monitoring and consumer engagement for varied aspects of population health, in its sale to Booz Allen Hamilton
  • bluebird bio in its acquisition of Precision Genome Engineering
  • Eloqua, a leading provider of on-demand revenue performance management software solutions, in its sale to Oracle Corporation
  • iRobot Corporation in its acquisition of Evolution Robotics
  • Endeca Technologies, a provider of unstructured data management, web commerce and business intelligence solutions, in its sale to Oracle Corporation
  • WaveMark, a provider of real-time healthcare supply chain solutions, in its sale to Cardinal Health
Professional Activities

Mr. Katz is a member of the Massachusetts and Boston Bar Associations. He also serves on the board of directors of the Hillel Council of New England.

Recognition

While attending law school, Mr. Katz was the articles editor of the Boston College Law Review, for which he authored "Conflicting Fiduciary Duties Within Collegiate Athletic Conferences: A Prescription for Leniency."

Credentials

Education

J.D., 2006
Boston College Law School

(magna cum laude, Order of the Coif)

A.B., 2001
Duke University

(magna cum laude)

Admissions

Bar

Massachusetts
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Search Other Lawyers